Survival outcome of adjuvant endocrine therapy alone for patients with lymph node-positive, hormone-responsive, HER2-negative breast cancer.
CONCLUSION: Several patients with clinicopathologic features like hormone receptor positivity and HER2 negativity can avoid chemotherapy even with lymph node metastasis. Future studies with a long-term follow-up and a larger number of patients are required for validating our results.
PMID: 30833157 [PubMed - as supplied by publisher]
Source: Asian Journal of Surgery - Category: Surgery Authors: Jung SU, Sohn G, Kim J, Chung IY, Lee JW, Kim HJ, Ko BS, Son BH, Ahn SH, Yang SW, Lee SB Tags: Asian J Surg Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Endocrine Therapy | HER2 | Hormonal Therapy | Hormones | Science | South Korea Health | Study | Surgery